Clinical trial
A Novel Nomogram to Predict Severity of COVID-19
NCT04366024 is registered in ClinicalTrials.gov with Xinqiao Hospital of Chongqing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel Nomogram to Predict Severity of COVID-19
- Lead sponsor
- Xinqiao Hospital of Chongqing
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 17, 2020
- Completion date
- December 31, 2021
- Enrollment
- 1,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 disease, nomogram model